![Nishant Saxena](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 531 278 $ per 2026-09-30
Nishant Saxena is currently Chief Business Officer at Corbus Pharmaceuticals Holdings, Inc. since 2026.
Formerly, Mr. Saxena was Chief Financial Officer at Jeune Aesthetics, Inc. Education includes undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-08-11 | 77 900 ( 0,4 % ) | 531 278 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Företagsledare/Principal | 2026-05-21 |
| Företag | Position | Slut |
|---|---|---|
Jeune Aesthetics, Inc.
 Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Finansdirektör/CFO | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Jeune Aesthetics, Inc.
Jeune Aesthetics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
